Skip Navigation
Skip to contents

ICDM 2024

Program details

Main symposia
Epidemiology and genetics 1 Caring for the future in GDM: pathways, precision, and prevention Chair(s): Hak Chul Jang, Mi Hae Seo
Thursday 10 October, 13:40~15:10
Room 3
This session offers a comprehensive exploration of Gestational Diabetes Mellitus (GDM) through diverse and interconnected topics. It begins with an examination of the heterogeneity and precision medicine of GDM, followed by insights into the link between metabolic dysfunction-associated fatty liver disease and cardiovascular disease in GDM patients. The session also highlights novel insights in diagnostic and treatment strategies for early gestational diabetes and emphasizes the importance of preventing the progression to type 2 diabetes postpartum.
Marie-France Hivert S8-1
Marie-France HivertHarvard University, USA
Heterogeneity of gestational diabetes: paving the path for precision medicine
Seung Mi Lee S8-2
Seung Mi LeeSeoul National University, Korea
MAFLD, connecting GDM and cardiovascular disease
Arianne Sweeting S8-3
Arianne SweetingUniversity of Sydney, Australia
Diagnosis and treatment of early gestational diabetes
Joon Ho Moon S8-4
Joon Ho MoonSeoul National University, Korea
Prevention of type 2 diabetes after GDM pregnancy
Epidemiology and genetics 2 Innovative data analysis and large-scale biobanks: transforming diabetes and metabolic disease research Chair(s): Hyeong-Kyu Park, Sang Youl Rhee
Thursday 10 October, 17:00~18:30
Room 3
With advancements in large-scale biobank datasets and analysis technologies, studies using innovative data analysis are being published. In this session, we will discuss research utilizing largescale biobanks and new analysis technologies in diabetes and metabolic diseases. We will introduce an in-silico score for coronary artery disease that uses machine learning to identify cardiometabolic disease markers from biobank data. We will also examine how precision nutrition is transforming diabetes management and treatment. Additionally, we will explore type 2 diabetes microbiome research findings from shotgun metagenomic analysis. Finally, we will present new insights into diabetes prevention and management from omics research conducted in the Korean diabetes prevention study.
Ron Do S11-1
Ron DoIcahn School of Medicine at Mount Sinai, USA
Machine learning-based prediction of coronary artery disease risk
Jordi Merino S11-2
Jordi MerinoUniversity of Copenhagen, Denmark
Precision nutrition in diabetes
Sunjae Lee S11-3
Sunjae LeeGIST, Korea
Risk stratifications of patients with T2D by integrative multi-omics approaches
Min-Jeong Shin S11-4
Min-Jeong ShinKorea University, Korea
Epigenetics in the management of cardiometabolic traits: lessons from the KDPS multi-omics study
Epidemiology and genetics 3 - KDA–KNIH–KGS joint session (K) Current status and challenges in elderly diabetes Chair(s): Kang Seo Park, Won-Ho Kim
Friday 11 October, 14:20~15:50
Room 3
Advancements in large-scale biobank datasets and analysis technologies are driving the publication of innovative research. In this session, we will discuss studies leveraging these resources in diabetes and metabolic diseases. We will introduce an in-silico score for coronary artery disease that employs machine learning to identify cardiometabolic disease markers from biobank data. We will also explore how precision nutrition is revolutionizing diabetes management and treatment. Additionally, we will review findings from type 2 diabetes microbiome research using shotgun metagenomic analysis. Finally, we will present new insights into diabetes prevention and management from the Korean Diabetes Prevention Study's omics research.
Seok-Jun Yoon S17-1
Seok-Jun YoonKorea University, Korea
Quantifying the disease burden of elderly diabetes
Young Jin Kim S17-2
Young Jin KimKorea National Institute of Health, Korea
Longitudinal study of accelerated aging and its relationship with type 2 diabetes
Kwang-il Kim S17-3
Kwang-il KimSeoul National University, Korea
Advancing geriatric care in elderly diabetes: insights from recent studies and research
Sung Wan Chun S17-4
Sung Wan ChunSoonchunhyang University, Korea
Research advances in metabolic regulation in elderly diabetes
Panel discussion
  • Joo Hyun Lim S17-Panel 1
    Joo Hyun LimKorea National Institute of Health, Korea
  • Eunok Bahng S17-Panel 2
    Eunok BahngKorea Disease Control and Prevention Agency, Korea
  • Kang Seo Park S17-Panel 3
    Kang Seo ParkEulji University, Korea
  • Jae-Seung Yun S17-Panel 4
    Jae-Seung YunThe Catholic University of Korea, Korea
KDA 대한당뇨병학회Korean Diabetes Association
  • (04146) 101-2104, Lotte Castle President, 109 Mapo-gu, Seoul, Korea
  • Tel: +82-2-714-9064 | E-mail: diabetes@kams.or.kr
  • Business Registration Number: 106-82-31108 | Name of Representative: Bong-Soo Cha
Congress Secretariat (Planbear)
  • #1101, 220, Gonghang-daero, Gangseo-gu, Seoul(07806), Republic of Korea
  • Tel: +82-2-6734-1008/1012/1013  E-mail: icdm@diabetes.or.kr